EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model

Identifikation wichtiger metabolischer Indikatoren bei der Komorbidität von ischämischem Schlaganfall und Diabetes mellitus mit einem interpretierbaren Clinlabomics-Modell

Yao Jiang, Ao Qian, Shu Chen, Qian Wu, Hao Xu, Chang Zheng, Fengyu Zhang, Wenli Xing, Jimin He

Frontiers in Cardiovascular Medicine · 24.06.2026 · 13

DOI: 10.3389/fcvm.2026.1874711 ↗

Auf einen Blick

Bei 2.587 Patient:innen mit ischämischem Schlaganfall wurden metabolische Marker für die Komorbidität mit Diabetes mellitus untersucht. Das rpart-Modell zeigte die beste Vorhersageleistung.

Fragestellung

Welche metabolischen Indikatoren sind mit der Komorbidität von ischämischem Schlaganfall und Diabetes mellitus assoziiert, und wie gut sagt ein Clinlabomics-Modell diese Konstellation vorher?

Methode

Retrospektive Analyse von 2.587 IS-Patient:innen; 16 metabolische Indikatoren; logistische Regression, RCS, LASSO und 11 ML-Algorithmen; 7:3-Split plus 406 Patient:innen zur zeitlichen Validierung.

Ergebnisse

12 Indikatoren waren in der multivariaten Regression assoziiert. TyG: OR 4,76 (95 %-KI 4,01–5,64); AIP: OR 3,60 (95 %-KI 2,74–4,72). Das rpart-Modell erreichte AUC 0,910; Test 0,839; zeitliche Validierung 0,873.

Schlussfolgerung der Autor:innen

Die Studie identifizierte 9 Kandidaten für metabolische Biomarker der IS-DM-Komorbidität. Das mit rpart etablierte Clinlabomics-Modell zeigte eine sehr gute Leistung zur Identifikation der IS-DM-Population.

Kernaussagen

  • TyG und AIP waren deutlich mit IS-DM assoziiert
  • rpart erzielte die beste Modellleistung
  • HbA1c/HDL-C war das wichtigste Feature in der SHAP-Analyse

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 24.06.2026. Verfasst von Yao Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Suining Central Hospital, Suining, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To identify candidate metabolic biomarkers and establish a Clinlabomics model for early precise screening of ischemic stroke (IS) with diabetes mellitus (DM) comorbidity population.

Methods

A total of 2,587 IS patients were retrospectively enrolled and classified into IS-DM comorbidity and IS-only groups. A total of 16 metabolic indicators were collected, and candidate indicators were identified using univariate and multivariate logistic regression along with restricted cubic spline (RCS) analysis. The dataset was randomly split into training and test sets at a 7:3 ratio, and an additional 406 patients constituted a temporal validation set. Clinlabomics models were constructed using 11 machine learning (ML) algorithms. Model performance was evaluated using F1-score, accuracy (ACC) and area under the curve (AUC) to select the optimal algorithm, and SHapley Additive exPlanations (SHAP) analysis was performed to quantify feature contributions.

Results

Multivariate logistic regression showed that 12 metabolic indicators were closely associated with IS-DM comorbidity. Notably, the triglyceride glucose (TyG) index (OR = 4.76, 95% CI: 4.01–5.64, P < 0.001) and atherogenic index of plasma (AIP) (OR = 3.60, 95% CI: 2.74–4.72, P < 0.001) were significantly associated with an increased risk of IS-DM comorbidity. RCS revealed non-linear associations between 9 indicators and comorbidity. Least Absolute Shrinkage and Selection Operator (LASSO) analysis identified 16 feature variables, and the recursive partitioning and regression trees (rpart) algorithm model achieved the best performance, with ACC, F1-score, AUC, sensitivity, and specificity of 0.885, 0.818, 0.910, 78%, and 94%, respectively. The AUC values in the training, test and temporal validation sets were 0.910 (95% CI: 0.894–0.926), 0.839 (95% CI: 0.807–0.871) and 0.873 (95% CI: 0.831–0.915), respectively. SHAP analysis suggested that glycated hemoglobin A1c (HbA1c)/high-density lipoprotein cholesterol (HDL-C) was the most important feature. Finally, 9 candidate metabolic biomarkers for comorbidity were identified, including TyG, uric acid (UA), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), AIP, atherogenic coefficient (AC), Castelli's risk index I (CRI-I), Castelli's risk index II (CRI-II), and HbA1c/HDL-C.

Conclusions

This study successfully identified 9 candidate metabolic indicators of IS-DM comorbidity. The Clinlabomics model established by rpart algorithm presents excellent performance in identifying the IS-DM population.

Schlagwörter

Stichwörter der Autor:innen

clinlabomics modelcomorbiditydiabetes mellitusischemic strokemachine learningmetabolic indicators

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Suining Central Hospital, Suining, China.
  • Department of Cerebrovascular Disease, Suining Central Hospital, Suining, China.
  • Faculty of Medical Technology, Shaanxi University of Chinese Medicine, Xi'an, China.
  • Department of Neurosurgery, Suining Central Hospital, Suining, China.

Zitieren

APA

Jiang, Y., Qian, A., Chen, S., Wu, Q., Xu, H., Zheng, C., Zhang, F., Xing, W., & He, J. (2026). Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1874711

Vancouver

Jiang Y, Qian A, Chen S, Wu Q, Xu H, Zheng C, et al. Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1874711

BibTeX
@article{Jiang2026,
  author = {Jiang, Yao and Qian, Ao and Chen, Shu and Wu, Qian and Xu, Hao and Zheng, Chang and Zhang, Fengyu and Xing, Wenli and He, Jimin},
  title = {Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1874711}
}
Kostenlos starten →